• 1
    Jepsen P, Vilstrup H, Sørensen HT. Alcoholic cirrhosis in Denmark — population-based incidence, prevalence, and hospitalization rates between 1988 and 2005: a descriptive cohort study. BMC Gastroenterol 2008; 8: 3.
  • 2
    Sørensen HT, Thulstrup AM, Mellemkjar L, Jepsen P, Christensen E, Olsen JH, et al. Long-term survival and cause-specific mortality in patients with cirrhosis of the liver: a nationwide cohort study in Denmark. J Clin Epidemiol 2003; 56: 8893.
  • 3
    Saunders JB, Walters JRF, Davies P, Paton A. A 20-year prospective study of cirrhosis. BMJ 1981; 282: 263266.
  • 4
    Garcia-Tsao G, D'Amico G, Abraldes JG, Schepis F, Merli M, Kim WR, et al. Predictive models in portal hypertension. In: de FranchisR, ed. Portal hypertension IV. Proceedings of the Fourth Baveno International Consensus Workshop. Oxford: Blackwell; 2006: 47102.
  • 5
    Fletcher RH, Fletcher SW. Prognosis. In: FletcherRH, FletcherSW, eds. Clinical epidemiology — the essentials. 3rd ed. Baltimore: Lippincott Williams & Wilkins; 2005: 105122.
  • 6
    Ratnoff OD, Patek AJ. The natural history of Laennec's cirrhosis of the liver — an analysis of 386 cases. Medicine (Baltimore) 1942; 21: 207268.
  • 7
    Powell WJ Jr, Klatskin G. Duration of survival in patients with Laennec's cirrhosis. Influence of alcohol withdrawal, and possible effects of recent changes in general management of the disease. Am J Med 1968; 44: 406420.
  • 8
    Stone WD, Islam NR, Paton A. The natural history of cirrhosis. Experience with an unselected group of patients. Q J Med 1968; 37: 119132.
  • 9
    Bell H, Jahnsen J, Kittang E, Raknerud N, Sandvik L. Long-term prognosis of patients with alcoholic liver cirrhosis: a 15-year follow-up study of 100 Norwegian patients admitted to one unit. Scand J Gastroenterol 2004; 39: 858863.
  • 10
    Pessione F, Ramond MJ, Peters L, Pham BN, Batel P, Rueff B, et al. Five-year survival predictive factors in patients with excessive alcohol intake and cirrhosis. Effect of alcoholic hepatitis, smoking and abstinence. Liver Int 2003; 23: 4553.
  • 11
    Ginès P, Quintero E, Arroyo V, Teres J, Bruguera M, Rimola A, et al. Compensated cirrhosis: natural history and prognostic factors. HEPATOLOGY 1987; 7: 122128.
  • 12
    D'Amico G, Morabito A, Pagliaro L, Marubini E. Survival and prognostic indicators in compensated and decompensated cirrhosis. Dig Dis Sci 1986; 31: 468475.
  • 13
    Kim YS, Um SH, Ryu HS, Lee JB, Lee JW, Park DK, et al. The prognosis of liver cirrhosis in recent years in Korea. J Korean Med Sci 2003; 18: 833841.
  • 14
    Turnes J, Garcia-Pagan JC, Abraldes JG, Hernandez-Guerra M, Dell'Era A, Bosch J. Pharmacological reduction of portal pressure and long-term risk of first variceal bleeding in patients with cirrhosis. Am J Gastroenterol 2006; 101: 506512.
    Direct Link:
  • 15
    Olsen J, Basso O, Sørensen HT. What is a population-based registry? Scand J Public Health 1999; 27: 78.
  • 16
    Andersen TF, Madsen M, Jørgensen J, Mellemkjær L, Olsen JH. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 1999; 46: 263268.
  • 17
    Juel K, Helweg-Larsen K. The Danish registers of causes of death. Dan Med Bull 1999; 46: 354357.
  • 18
    Stewart CA, Smith GE. Minimal hepatic encephalopathy. Nat Clin Pract Gastroenterol Hepatol 2007; 4: 677685.
  • 19
    Elsass P, Christensen SE, Ranek L. Continuous reaction time in patients with hepatic encephalopathy. A quantitative measure of changes in consciousness. Scand J Gastroenterol 1981; 16: 441447.
  • 20
    Rimola A, Garcia-Tsao G, Navasa M, Piddock LJ, Planas R, Bernard B, et al. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. J Hepatol 2000; 32: 142153.
  • 21
    Lucey MR, Connor JT, Boyer TD, Henderson JM, Rikkers LF. Alcohol consumption by cirrhotic subjects: patterns of use and effects on liver function. Am J Gastroenterol 2008; 103: 16981706.
    Direct Link:
  • 22
    Frank L. When an entire country is a cohort. Science 2000; 287: 23982399.
  • 23
    Christensen E, Schlichting P, Andersen PK, Fauerholdt L, Schou G, Pedersen BV, et al. Updating prognosis and therapeutic effect evaluation in cirrhosis with Cox's multiple regression model for time-dependent variables. Scand J Gastroenterol 1986; 21: 163174.
  • 24
    Satten GA, Datta S, Robins J. Estimating the marginal survival function in the presence of time dependent covariates. Stat Prob Lett 2001; 54: 397403.
  • 25
    Andersen PK, Keiding N. Multi-state models for event history analysis. Stat Methods Med Res 2002; 11: 91115.
  • 26
    Hamberg KJ, Carstensen B, Sørensen TI, Eghøje K. Accuracy of clinical diagnosis of cirrhosis among alcohol-abusing men. J Clin Epidemiol 1996; 49: 12951301.
  • 27
    Jepsen P, Vilstrup H, Andersen PK, Lash TL, Sørensen HT. Comorbidity and survival of Danish cirrhosis patients: a nationwide population-based cohort study. HEPATOLOGY 2008; 48: 214220.
  • 28
    D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 2006; 44: 217231.
  • 29
    Zipprich A, Dollinger MM, Garcia-Tsao G, Rogowski S, Fleig WE. Prognostic indicators of survival in compensated and decompensated stages of liver cirrhosis: validation of a 4-stage classification [Abstract]. J Hepatol 2008; 48: S125S126.
  • 30
    Stokkeland K, Brandt L, Ekbom A, Hultcrantz R. Improved prognosis for patients hospitalized with esophageal varices in Sweden 1969-2002. HEPATOLOGY 2006; 43: 500505.
  • 31
    Krige JE, Kotze UK, Bornman PC, Shaw JM, Klipin M. Variceal recurrence, rebleeding, and survival after endoscopic injection sclerotherapy in 287 alcoholic cirrhotic patients with bleeding esophageal varices. Ann Surg 2006; 244: 764770.